The review included double-blinded, randomized controlled trials (RCTs), published in any language, comparing a combination of 2 or more nonopioid analgesics to at least one of the combination's individual components and/or placebo in reducing cancer-related pain. Both parallel and crossover study designs were considered. Nonrandomized and/or nonblinded studies were excluded.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.